Speed-date event
Description
For students and jobseekers in biomedical technology.
25 November, the KIVI NIRIA Department of Biomedical Technology, in collaboration with Syntens, is organising a contact afternoon between students/ jobseekers and 10 employers from small and medium-sized enterprises. After two high-profile presentations, you will meet 5 companies in rounds of 10-minute talks. In these talks, you can explore whether there is a match between you as a (future) jobseeker and the companies.
Of course, this also applies to the SME entrepreneur. And because KIVI NIRIA considers it so important that the student's education and profile match the needs of the business community, we also see this speed dating meeting as an event from which we want to learn something in that sense.
Programme:
14.45 h Reception with coffee and tea
15.00 h Welcome by Jan Dekker, President KIVI NIRIA
15.10 h Presentation 1: Herman Telle, programme leader TechnoTalentGroep
15.35 hrs Presentation 2 : Ruud Verdaasdonk, innovation coordinator Medical Technology and Clinical Physics, UMC Utrecht
16.00 hrs Break
16.15 hrs Company Pitches
16.30 hrs Speed dating (5 rounds of 10 minutes)
17.30 hrs Closing chat with drinks until 18.30 pm.
The participating companies are:
- Medical Technological Innovation Centre
- Forcare BV Zeist
- Step2 Innovation Utrecht
- Medis Medical Imaging Systems
- Luminostix Capelle a/d IJssel
- Design and Technology of Instrumentation, EHV
- School for Medical Physics and Engineering, EHV
- O2view Marken
- Prosensa Therapeutics Leiden
- BioTop Medical Leiden
Are you - as a company - interested in signing up as a company at this speed date? If so, please contact Willem Schroeijers, wss@syntens.nl.
Syntens is an initiative of the Ministry of Economic Affairs.
CONTENTS
There is a maximum of 30 participants, there are still some places available, so register quickly!
Location
KIVI NIRIA building, Prinsessegracht 23
The Hague
Organiser
Medical Technology
Syntens
Name and contact details for information
Further information from Elfride Dijkstra at the e-mail address below